Cargando…

Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non–Small Cell Lung Cancer

Loss of basement membrane (BM) integrity is typically associated with cancer. Nidogen-1 is an essential component of the BM. Nidogen-1 is a substrate for cathepsin-S (CatS) which is released into the tumor microenvironment. Measuring nidogen-1 degraded by CatS may therefore have biomarker potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willumsen, Nicholas, Bager, Cecilie L., Leeming, Diana J., Bay-Jensen, Anne-Christine, Karsdal, Morten A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344320/ https://www.ncbi.nlm.nih.gov/pubmed/28282545 http://dx.doi.org/10.1016/j.neo.2017.01.008

Ejemplares similares

Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls
por: Willumsen, Nicholas, et al.
Publicado: (2013)

Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer
por: Willumsen, Nicholas, et al.
Publicado: (2014)

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker
por: Kehlet, S.N., et al.
Publicado: (2017)

Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer – A Proof of Concept Study
por: Willumsen, Nicholas, et al.
Publicado: (2019)

Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer
por: Willumsen, Nicholas, et al.
Publicado: (2017)

Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2020)

Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
por: Wang, Song, et al.
Publicado: (2021)

Cleavage of Nidogen-1 by Cathepsin S Impairs Its Binding to Basement Membrane Partners
por: Sage, Juliette, et al.
Publicado: (2012)

Autoreactivity against Denatured Type III Collagen Is Significantly Decreased in Serum from Patients with Cancer Compared to Healthy Controls
por: Jensen, Christina, et al.
Publicado: (2023)

Matrix metalloproteinase-degraded type I collagen is associated with APOE/TOMM40 variants and preclinical dementia
por: Tang, Man-Hung Eric, et al.
Publicado: (2020)

In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
por: Drobinski, Patryk J., et al.
Publicado: (2022)

Incidence of total hip and total knee replacements from the prospective epidemiologic risk factor study: considerations for event driven clinical trial design
por: Bager, Cecilie L., et al.
Publicado: (2019)

A synaptic nidogen: Developmental regulation and role of nidogen-2 at the neuromuscular junction
por: Fox, Michael A, et al.
Publicado: (2008)

Distribution of Nidogen in the Murine Eye and Ocular Phenotype of the Nidogen-1 Knockout Mouse
por: May, Christian Albrecht
Publicado: (2012)

Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade
por: Jensen, Christina, et al.
Publicado: (2020)

Tumstatin, a Matrikine Derived from Collagen Type IVα3, is Elevated in Serum from Patients with Non–Small Cell Lung Cancer
por: Nielsen, Signe Holm, et al.
Publicado: (2018)

Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease
por: Nissen, Neel Ingemann, et al.
Publicado: (2019)

Diagnosis of Osteoarthritis by Cartilage Surface Smoothness Quantified Automatically from Knee MRI
por: Tummala, Sudhakar, et al.
Publicado: (2011)

Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis
por: Bay-Jensen, Anne C., et al.
Publicado: (2013)

Molecular Serum Markers of Liver Fibrosis
por: Liu, Tianhui, et al.
Publicado: (2012)

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis
por: Leeming, D.J., et al.
Publicado: (2018)

Dynamic compression inhibits cytokine-mediated type II collagen degradation
por: Engstrøm, Amalie, et al.
Publicado: (2022)

Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling
por: Kristensen, Jacob H, et al.
Publicado: (2015)

Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders()()
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes
por: Barascuk, Natasha, et al.
Publicado: (2010)

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
por: Nissen, Neel I., et al.
Publicado: (2019)

Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma
por: Nissen, Neel I., et al.
Publicado: (2022)

An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution
por: Pehrsson, Martin, et al.
Publicado: (2022)

Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis
por: Vassiliadis, Efstathios, et al.
Publicado: (2011)

Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
por: Flies, Dallas B., et al.
Publicado: (2023)

Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer
por: Thorlacius‐Ussing, Jeppe, et al.
Publicado: (2023)

Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women
por: Bertelsen, Ditte Marie, et al.
Publicado: (2018)

Nidogen‐1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration
por: Zbinden, Aline, et al.
Publicado: (2020)

Cancer risk in relation to body fat distribution, evaluated by DXA-scans, in postmenopausal women – the Prospective Epidemiological Risk Factor (PERF) study
por: Staunstrup, Line Mærsk, et al.
Publicado: (2019)

Serological assessment of collagen fragments and tumor fibrosis may guide immune checkpoint inhibitor therapy
por: Jensen, Christina, et al.
Publicado: (2021)

Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types
por: Willumsen, Nicholas, et al.
Publicado: (2022)

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients
por: Jensen, Christina, et al.
Publicado: (2020)

Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-Epitope Approach in the Development of New Biomarkers
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
por: Willumsen, Nicholas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bi1fdbd3s07vh4molr5hap9a1v